William Barlow
· Research ProfessorUniversity of Washington · Biostatistics
Active 1894–2026
Academic metrics are sourced from OpenAlex and public funding records; values may differ from Google Scholar.
About
William E. Barlow is a Research Professor in the Department of Biostatistics at the University of Washington School of Public Health. He holds a BA in Psychology from Western Washington University, an MA in Psychology from the University of Toronto, and both MS and PhD degrees in Biostatistics from the University of Washington. His research interests include biomarkers, clinical trials, survival analysis, cancer research, epidemiology, medical diagnostics, ophthalmology, and sports statistics. Barlow's work focuses on applying biostatistical methods to various medical and health-related fields, contributing to scientific collaborations and consulting services within the university. His extensive background in biostatistics supports his role in advancing research and education in public health.
Research topics
- Physical therapy
- Internal medicine
- Oncology
- Medicine
Selected publications
2025-06-03
preprintOpen access<p>Supplementary Methods 1</p>
2025-06-03
supplementary-materialsOpen access<p>Supplementary Table 7. Median overall survival (OS) and hazard ratios for the CTC change groups as categorized based on the ≥5 CTC cutoff for CTC positivity (reference group neg/neg) for patients with hormone receptor-positive/HER2-negative, HER2-positive and triple-negative tumors.</p>
2025-06-03
supplementary-materialsOpen access<p>Supplementary Table 3: Comparisons of the probabilities of being CTC positive among tumor subtypes (hormone receptor-positive/HER2-negative, HER2-positive, triple-negative) according to time point of CTC assessment (baseline, first follow-up) and cutoff for CTC positivity (≥1 CTC, ≥5 CTCs). Probabilities of being CTC positive are given in terms of percentages and odds ratios with 95% confidence intervals (CI) obtained using binary logistic regression models with the response variable CT…
2025-06-03
supplementary-materialsOpen access<p>Supplementary Table 5: Comparisons of the probabilities of patients that are CTC positive at baseline being a CTC responder (i.e., switching from CTC positive at baseline to CTC negative at first follow-up) among tumor subtypes (hormone receptor-positive/HER2-negative, HER2-positive, triple-negative) according to cutoff for CTC positivity (≥1 CTC, ≥5 CTCs). Probabilities of being a CTC responder are given in terms of percentages and odds ratios with 95% confidence intervals (CI) obtaine…
2025-06-03
supplementary-materialsOpen access<p>Supplementary Table 4: Comparisons of the probabilities of being CTC positive betweenHER2- positive/hormone receptor-positive and HER2-positive/hormone receptor-negative tumors according to time point of CTC assessment (baseline, first follow-up) and cutoff for CTC positivity (≥1 CTC, ≥5 CTCs). Probabilities of being CTC positive are given in terms of percentages and odds ratios with 95% confidence intervals (CI) obtained using binary logistic regression models with the response variabl…
Recent grants
NIH · $8.5M · 2011
PROSPR Statistical Coordinating Center (PSCC)
NIH · $7.5M · 2011–2018
NIH · $127k · 1995
Frequent coauthors
- 444 shared
Gabriel N. Hortobágyi
- 437 shared
Kathy S. Albain
Loyola University Chicago
- 432 shared
Robert B. Livingston
- 425 shared
Dawn L. Hershman
Columbia University Irving Medical Center
- 417 shared
Julie R. Gralow
- 392 shared
Joann G. Elmore
University of California, Los Angeles
- 380 shared
Jo Anne Zujewski
Olema Pharmaceuticals (United States)
- 349 shared
Stephen H. Taplin
Labs
William Barlow LabPI
Similar researchers at University of Washington
- Resume-aware match score
- Save to shortlist
- AI-drafted outreach
See your match with William Barlow
PhdFit ranks faculty by your research interests, methods, and publications — grounded in their actual work, not templates.
- Free to start
- No credit card
- 30-second signup